Henry Gosebruch
Chief Executive Officer at NEUMORA THERAPEUTICS, INC.
Net worth: 9 M $ as of 30/12/2023
Profile
Henry O.
Gosebruch is currently the President, Chief Executive Officer & Director at Neumora Therapeutics, Inc. and a Director at ACELYRIN, Inc. Previously, he served as an Independent Director at Aptinyx, Inc. from 2019 to 2023.
Prior to that, he was the Chief Strategy Officer & Executive Vice President at AbbVie, Inc. from 2015 to 2023 and Co-Head of Mergers & Acquisitions North America at JPMorgan Securities LLC from 1995 to 2015.
He received his undergraduate degree from The Wharton School of the University of Pennsylvania in 1995.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/02/2024 | 604,793 ( 0.38% ) | 8 M $ | 30/03/2024 | |
ACELYRIN, INC.
0.05% | 08/05/2023 | 50,000 ( 0.05% ) | 337 500 $ | 30/03/2024 |
APTINYX INC
0.18% | 23/04/2023 | 125,000 ( 0.18% ) | 12 000 $ | 30/12/2023 |
Henry Gosebruch active positions
| Companies | Position | Start |
|---|---|---|
| ACELYRIN, INC. | Director/Board Member | 28/03/2023 |
| NEUMORA THERAPEUTICS, INC. | Chief Executive Officer | 17/07/2023 |
Former positions of Henry Gosebruch
| Companies | Position | End |
|---|---|---|
| APTINYX | Director/Board Member | 03/05/2023 |
| ABBVIE INC. | Corporate Officer/Principal | 31/01/2023 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 30/11/2015 |
Training of Henry Gosebruch
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ABBVIE INC. | Health Technology |
| APTINYX | Health Technology |
| ACELYRIN, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
- Stock Market
- Insiders
- Henry Gosebruch
